Inventor

DELLINGER RYAN

US16 patents

⚠️ This page may combine multiple inventors who share the name “DELLINGER RYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHROMADEX INC

8 patents

US10000520B2Jun 19, 2018

B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

CHROMADEX INC6 citations80

US10280190B2May 7, 2019

Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions

CHROMADEX INC6 citations71

US10934322B2Mar 2, 2021

B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

CHROMADEX INC4 citations69

US10183036B2Jan 22, 2019

Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors

CHROMADEX INC6 citations68

US12433908B2Oct 7, 2025

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

CHROMADEX INC0 citations57

US11524022B2Dec 13, 2022

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

CHROMADEX INC0 citations57

US10857172B2Dec 8, 2020

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

CHROMADEX INC0 citations46

US10039725B2Aug 7, 2018

Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene

CHROMADEX INC0 citations45

ELYSIUM HEALTH INC

7 patents

US12043616B2Jul 23, 2024

BARTOS JEREMY

1 patent

US8841350B2Sep 23, 2014

Method for inducing UDP-glucuronosyltransferase activity using pterostilbene

BARTOS JEREMY2 citations50

DELLINGER RYAN

CHROMADEX INC

B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions

B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene

ELYSIUM HEALTH INC

Crystalline forms of nicotinamide riboside chloride

Crystalline forms of nicotinamide riboside chloride

Methods of synthesizing nicotinamide riboside

Treating and preventing kidney damage

Nicotinamide riboside for use in treating or preventing liver damage

Nicotinamide riboside for use in treating or preventing liver damage

Treating and preventing motor neuron diseases using nicotinamide riboside

BARTOS JEREMY

Method for inducing UDP-glucuronosyltransferase activity using pterostilbene